Skip to main content
Log in

Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Patients with spinal cord deficits following new unstable osteoporotic compression fracture and surgical contraindications were considered to receive conservative treatment. Teriparatide was better than alendronate at improving bone mineral density and bone turnover parameters, as well as preventing aggravation of spinal cord compromise.

Introduction

This study compared the preventive effects of teriparatide and alendronate on aggravation of spinal cord compromise following new unstable osteoporotic vertebral compression fracture (OVCF) in patients with surgical contraindications.

Methods

This was a 12-month, randomized, open-label study of teriparatide versus alendronate in 49 patients with new unstable OVCF and surgical contraindications. Neurological function was evaluated using modified Japanese Orthopedic Association (mJOA) score (11-point scale, the maximum score of 11 implies normalcy). Visual analog scale (VAS) scores, kyphotic angles, anterior-border heights and diameters of the spinal canal of the fractured vertebrae, any incident of new OVCFs (onset of OVCF during follow-up), spine bone mineral density (BMD), and serum markers of bone resorption and bone formation were also examined at baseline and 1, 3, 6, and 12 months after initiation of the medication regimen.

Results

At 12 months, mean mJOA score had improved in the teriparatide group and decreased in the alendronate group. Mean concentrations of bone formation and bone resorption biomarkers, mean spine BMD, and mean anterior-border height and spinal canal diameter of the fractured vertebrae were significantly greater in the teriparatide group than in the alendronate group. Mean VAS score, mean kyphotic angle of the fractured vertebrae, and incidence of new OVCFs were significantly smaller in the teriparatide group than in the alendronate group.

Conclusions

In patients with neurological deficits following new unstable OVCF and with surgical contraindications, teriparatide was better than alendronate at improving the BMD and the bone turnover parameters, as well as preventing aggravation of spinal cord compromise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–7

    Article  PubMed  Google Scholar 

  2. Lee HM, Park SY, Lee SH, Suh SW, Hong JY (2012) Comparative analysis of clinical outcomes in patients with osteoporotic vertebral compression fractures (OVCFs): conservative treatment versus balloon kyphoplasty. Spine J 12:998–1005

    Article  PubMed  Google Scholar 

  3. Kim DH, Vaccaro AR (2006) Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J 6:479–487

    Article  PubMed  Google Scholar 

  4. Patil S, Rawall S, Singh D, Mohan K, Nagad P, Shial B, Pawar U, Nene A (2013) Surgical patterns in osteoporotic vertebral compression fractures. Eur Spine J 22:883–891

    Article  PubMed  Google Scholar 

  5. Gao C, Wei D, Yang H, Chen T, Yang L (2015) Nanotechnology for treating osteoporotic vertebral fractures. Int J Nanomedicine 10:5139–5157

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Kim HJ, Yi JM, Cho HG, Chang BS, Lee CK, Kim JH, Yeom JS (2014) Comparative study of the treatment outcomes of osteoporotic compression fractures without neurologic injury using a rigid brace, a soft brace, and no brace: a prospective randomized controlled non-inferiority trial. J Bone & Joint Surg 96:1959–1966

    Article  Google Scholar 

  7. Farahmand P, Marin F, Hawkins F et al (2013) Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int 24:2971–2981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA (2007) Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone and Min Res 22:149–157

    Article  CAS  Google Scholar 

  9. Park JH, Kang KC, Shin DE, Koh YG, Son JS, Kim BH (2014) Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture. Osteoporos Int 25:613–618

    Article  PubMed  Google Scholar 

  10. Sudo H, Ito M, Kaneda K, Abumi K, Kotani Y, Nagahama K, Minami A, Iwasaki N (2013) Anterior decompression and strut graft versus posterior decompression and pedicle screw fixation with vertebroplasty for osteoporotic thoracolumbar vertebral collapse with neurologic deficits. Spine J 13:1726–1732

    Article  PubMed  Google Scholar 

  11. Guglielmi G, Andreula C, Muto M, Gilula LA (2005) Percutaneous vertebroplasty: indications, contraindications, technique, and complications. Acta Radiol 46:256–268

    Article  CAS  PubMed  Google Scholar 

  12. Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148

    Article  CAS  PubMed  Google Scholar 

  13. Desai SK, Vadivelu S, Patel AJ, Brayton A, Jea A (2013) Isolated cervical spinal canal stenosis at C-1 in the pediatric population and in Williams syndrome. J Neurosurg Spine 18:558–563

    Article  PubMed  Google Scholar 

  14. Fujiwara A, Kobayashi N, Saiki K, Kitagawa T, Tamai K, Saotome K (2003) Association of the Japanese orthopaedic association score with the oswestry disability index, roland-morris disability questionnaire, and short-form 36. Spine 28:1601–1607

    PubMed  Google Scholar 

  15. Sudo H, Ito M, Abumi K, Kotani Y, Takahata M, Hojo Y, Minami A (2010) One-stage posterior instrumentation surgery for the treatment of osteoporotic vertebral collapse with neurological deficits. Eur Spine J 19:907–915

    Article  PubMed  PubMed Central  Google Scholar 

  16. Aizawa T, Sato T, Sasaki H, Kusakabe T, Morozumi N, Kokubun S (2006) Thoracic myelopathy caused by ossification of the ligamentum flavum: clinical features and surgical results in the Japanese population. J Neurosurg Spine 5:514–519

    Article  PubMed  Google Scholar 

  17. Yonenobu K, Ebara S, Fujiwara K, Yamashita K, Ono K, Yamamoto T, Harada N, Ogino H, Ojima S (1987) Thoracic myelopathy secondary to ossification of the spinal ligament. J Neurosurg 66:511–518

    Article  CAS  PubMed  Google Scholar 

  18. SCOTT PJ, Huskisson E (1977) Measurement of functional capacity with visual analogue scales. Rheumatology 16:257–259

    Article  CAS  Google Scholar 

  19. Ammann P, Rizzoli R (2003) Bone strength and its determinants. Osteoporos Int 14(Suppl 3):S13–18

    Article  PubMed  Google Scholar 

  20. Roberto Izzoa GG, Giuseppe Guglielmib, Mario Mutoa (2013) Biomechanics of the spine. Part I: Spinal stability. Eur J Radiol 82

  21. Roberto Izzoa GG, Giuseppe Guglielmib, Mario Mutoa (2013) Biomechanics of the spine. Part II: Spinal instability. Eur J Radiol 82:12

  22. Tu PH, Liu ZH, Lee ST, Chen JF (2012) Treatment of repeated and multiple new-onset osteoporotic vertebral compression fractures with teriparatide. J Clin Neurosci 19:532–535

    Article  CAS  PubMed  Google Scholar 

  23. Ataka H, Tanno T, Yamazaki M (2009) Posterior instrumented fusion without neural decompression for incomplete neurological deficits following vertebral collapse in the osteoporotic thoracolumbar spine. Eur Spine J 18:69–76

    Article  PubMed  Google Scholar 

  24. Kashii M, Yamazaki R, Yamashita T et al (2013) Surgical treatment for osteoporotic vertebral collapse with neurological deficits: retrospective comparative study of three procedures--anterior surgery versus posterior spinal shorting osteotomy versus posterior spinal fusion using vertebroplasty. Eur Spine J 22:1633–1642

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nevitt MC, Chen P, Dore RK, Reginster J-Y, Kiel DP, Zanchetta JR, Glass EV, Krege JH (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17:273–280

    Article  PubMed  Google Scholar 

  26. Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y (2012) Randomized Teriparatide [human parathyroid hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol & Metab 97:3097–3106

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work has been supported by the National Science Foundation of China 81471403 and 30973024. Ruoyan Xue contributed equally with the first author Ying Zhao in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y. Xue.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, Y., Xue, R., Shi, N. et al. Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications. Osteoporos Int 27, 3309–3317 (2016). https://doi.org/10.1007/s00198-016-3651-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3651-2

Keywords

Navigation